Efficacy of Early Intensive ROsuvastatin Therapy in Patients With ST-segment Elevation Myocardial Infarction Undergoing PrimARY Percutaneous Coronary Intervention (the ROSEMARY Trial).
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms ROSEMARY
- 16 Apr 2014 Results published in the American Journal of Cardiology.
- 04 Mar 2014 Planned End Date changed from 1 Jun 2012 to 1 Mar 2015 as reported by ClinicalTrials.gov.
- 04 Sep 2013 Primary endpoint 'Myocardial-infarct-size' has not been met.